Tricida Announces Second Quarter 2022 Financial Results by Seini Moimoi | Aug 13, 2022 | Portfolio News
Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Fibromyalgia by Seini Moimoi | Aug 12, 2022 | Portfolio News
Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2022 by Seini Moimoi | Aug 11, 2022 | Portfolio News
Nabriva Therapeutics Completes Patient Enrollment in Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis by Seini Moimoi | Aug 11, 2022 | Portfolio News
Molecular Templates, Inc. Reports Second Quarter 2022 Financial Results by Seini Moimoi | Aug 11, 2022 | Portfolio News
Theseus Pharmaceuticals Announces Business and Pipeline Highlights and Reports Second Quarter 2022 Financial Results by Seini Moimoi | Aug 11, 2022 | Portfolio News
89bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update by Seini Moimoi | Aug 11, 2022 | Portfolio News
Kala Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update by Seini Moimoi | Aug 11, 2022 | Portfolio News
Vaxcyte Reports Second Quarter 2022 Financial Results and Provides Business Update by Seini Moimoi | Aug 8, 2022 | Portfolio News
